Metastatic Endometrial Endometrioid Adenocarcinoma (DBCOND0151674)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05538897	Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers	Ipatasertib Megestrol Megestrol acetate	treatment	1 / 2	recruiting